.RESEARCH STUDY EMPHASIZE.06 August 2024.
A large randomized measured test along with cisgender women highlights the problems of faithfulness to an everyday oral preexposure prevention program as well as shows that twice-yearly injection of lenacapavir may preserve helpful HIV avoidance degrees over 6 months.